Plugging the Hole in Part D: CMS Tries to Sweeten the Deal for Enhanced Medicare Drug Coverage
This article was originally published in RPM Report
Executive Summary
The federal Medicare agency is desperate to woo Part D plans to provide brand name drug coverage in the "donut hole" for 2008 despite the catastrophic failure of enhanced plans so far. Manufacturers should root for CMS to make it happen-but prepare for the fallout if the agency can't.
You may also be interested in...
Medicare Rx in 2009: Re-Politicizing Drug Prices
Remember when the Democrats took over Congress and promised to do something about prescription drug prices under Part D? They didn't get very far, and they haven't been talking about it since. But when beneficiaries get ready to renew their Part D coverage in 2009-and see how much their costs are going up-there may be a lot more to talk about.
Medicare Rx at a Turning Point: Big Plans Stumble as Part D Enters a Pivotal Year
United, Humana and especially WellCare are taking their licks in the run-up to the third year of the Medicare prescription drug program. That is just the latest warning sign for pharma and biotech companies that a critical market is entering a critical turning point.
Medicare Rx at a Turning Point: Big Plans Stumble as Part D Enters a Pivotal Year
United, Humana and especially WellCare are taking their licks in the run-up to the third year of the Medicare prescription drug program. That is just the latest warning sign for pharma and biotech companies that a critical market is entering a critical turning point.